475489-37-3

Usage

Uses

Used in Pharmaceutical Drug Development:
5-(3-(benzyloxy)phenyl)-5H-pyrrolo[2,3-d]pyrimidin-4-amine is used as a kinase inhibitor for the development of pharmaceutical drugs targeting various diseases, particularly cancer. Its kinase inhibitory activity suggests its potential in treating cancer by modulating cellular signaling pathways involved in tumor growth and progression.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 5-(3-(benzyloxy)phenyl)-5H-pyrrolo[2,3-d]pyrimidin-4-amine serves as a valuable compound for research and development. Its unique structure and biological activities make it a promising candidate for the discovery of new therapeutic agents with improved efficacy and safety profiles.
Used in Cancer Treatment:
5-(3-(benzyloxy)phenyl)-5H-pyrrolo[2,3-d]pyrimidin-4-amine is used as a potential cancer treatment agent due to its kinase inhibitory activity. It may be employed in the development of drugs that target specific cancer-related pathways, offering a new approach to cancer therapy.
Used in Drug Design and Optimization:
In the process of drug design and optimization, 5-(3-(benzyloxy)phenyl)-5H-pyrrolo[2,3-d]pyrimidin-4-amine can be utilized as a starting point for the synthesis of analogs with enhanced biological activities and selectivity. Further research and development of PDP and its derivatives could lead to the creation of novel therapeutic agents with improved pharmacological properties.
Used in Preclinical and Clinical Studies:
5-(3-(benzyloxy)phenyl)-5H-pyrrolo[2,3-d]pyrimidin-4-amine may be employed in preclinical and clinical studies to evaluate its safety, efficacy, and potential side effects as a therapeutic agent. These studies are crucial for determining the suitability of PDP for use in human patients and its potential as a treatment option for various diseases, including cancer.

InChI:InChI=1/C19H16N4O/c20-18-17-16(10-21-19(17)23-12-22-18)14-7-4-8-15(9-14)24-11-13-5-2-1-3-6-13/h1-10,12H,11H2,(H3,20,21,22,23)